Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Anna Marrs sold 363 shares of the firm’s stock in a transaction dated Friday, December 5th. The shares were sold at an average price of $64.50, for a total transaction of $23,413.50. Following the completion of the sale, the director owned 11,525 shares in the company, valued at $743,362.50. This represents a 3.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Anna Marrs also recently made the following trade(s):
- On Tuesday, December 2nd, Anna Marrs sold 365 shares of Docusign stock. The stock was sold at an average price of $68.54, for a total transaction of $25,017.10.
- On Monday, September 15th, Anna Marrs sold 728 shares of Docusign stock. The shares were sold at an average price of $80.30, for a total transaction of $58,458.40.
Docusign Price Performance
NASDAQ DOCU traded down $5.43 on Friday, hitting $65.67. The stock had a trading volume of 8,925,162 shares, compared to its average volume of 2,738,978. The business’s fifty day moving average price is $69.80 and its 200 day moving average price is $75.45. The stock has a market cap of $13.21 billion, a price-to-earnings ratio of 49.38, a price-to-earnings-growth ratio of 3.51 and a beta of 0.98. Docusign Inc. has a 52-week low of $63.41 and a 52-week high of $107.86.
Analysts Set New Price Targets
Several analysts have commented on the stock. Argus restated a “hold” rating on shares of Docusign in a research note on Monday, September 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Docusign in a report on Wednesday, October 8th. Zacks Research downgraded Docusign from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Evercore ISI decreased their price objective on Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a report on Friday. Finally, Bank of America lowered their target price on Docusign from $102.00 to $82.00 and set a “neutral” rating on the stock in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating and sixteen have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $86.71.
Read Our Latest Stock Analysis on DOCU
Institutional Investors Weigh In On Docusign
Institutional investors have recently made changes to their positions in the stock. Mackenzie Financial Corp lifted its position in shares of Docusign by 9.9% during the 1st quarter. Mackenzie Financial Corp now owns 3,455 shares of the company’s stock worth $281,000 after purchasing an additional 311 shares during the last quarter. US Bancorp DE increased its position in Docusign by 17.9% during the 1st quarter. US Bancorp DE now owns 4,648 shares of the company’s stock worth $378,000 after purchasing an additional 706 shares during the period. PNC Financial Services Group Inc. grew its stake in shares of Docusign by 5.5% during the 1st quarter. PNC Financial Services Group Inc. now owns 6,888 shares of the company’s stock worth $561,000 after purchasing an additional 356 shares during the period. Atria Wealth Solutions Inc. boosted its stake in shares of Docusign by 4.1% during the 1st quarter. Atria Wealth Solutions Inc. now owns 9,327 shares of the company’s stock worth $759,000 after acquiring an additional 369 shares in the last quarter. Finally, iA Global Asset Management Inc. raised its stake in shares of Docusign by 2.1% during the 1st quarter. iA Global Asset Management Inc. now owns 7,712 shares of the company’s stock worth $628,000 after buying an additional 157 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors and hedge funds.
About Docusign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Recommended Stories
- Five stocks we like better than Docusign
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- What is the Nikkei 225 index?
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- What Are the FAANG Stocks and Are They Good Investments?
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
